Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
A recent study conducted by researchers with the University of California reveals the lengths people are willing to go to avoid taking daily medication. One-third of people surveyed said they would rather risk an early death than take a daily pill to prevent heart disease, and a fifth of those polled would pay at least $1,000 to avoid taking medication daily. The survey was initially designed to see just how much time at the end of their lives people would be willing to give up to avoid taking preventative medications every day, and how much they would be willing to pay to ... Read More
An additional 1,400 patients who had received a DePuy ARS metal-on-metal hip implant are now eligible to participate in the U. S. Settlement Program to receive compensation for their revision surgeries. DePuy Orthopaedics, a subsidiary of Johnson & Johnson, announced that it has agreed to extend the existing U.S. Settlement Program to include eligible patients in the U.S. who had surgery to remove and replace their defective implants after Aug. 31, 2013 and on or before Jan. 31, 2015. The previous settlement, announced in November 2013, did not compensate eligible patients who had revision surgery after Aug. 30, 2013. The agreement ... Read More
People who have taken specific antibiotics repeatedly may be more likely to develop type 2 diabetes, according to a new study published in the European Journal of Endocrinology. For the study, researchers examined the number of antibiotic prescriptions among 200,000 people with diabetes at least one year before they were diagnosed with the disease. That total was compared to the number of antibiotics prescribed to 800,000 people the same average age as the previous group but who did not have diabetes. Researchers found that the more courses of antibiotics patients were prescribed, the greater their risk of diabetes. The types ... Read More
Merck & Co.’s cancer drug Keytruda (pembrolizumab) was superior in treating patients of advanced melanoma in phase III clinical trials compared to Bristol-Myers Squibb Co.’s Yervoy (ipilimumab). Keytruda is in a class of cancer drugs known as PD-1 inhibitors. It is currently approved for the treatment of unresectable or metastatic melanoma, and in patients whose disease has progressed after the use of the standard treatment, Yervoy. The positive results of the latest trial of Keytruda is good news for the large number of patients worldwide with skin cancer. Melanoma is the deadliest form of skin cancer because it can be ... Read More
A recent U.S. Food and Drug Administration (FDA) Safety Communication is reminding all patients to confirm that the medical facility where they are receiving mammograms are MQSA-certified in order to better assure the quality of their assessment. This notice follows on the heels of an effort to advise patients who were treated by Richard D. Adelman, M.D., Family Medicine Practice in Raleigh, N.C., anytime after Aug. 24, 2012, that there were possible problems with the quality of the mammograms performed by the practice, and that follow-up testing by a certified facility may be necessary. The American College of Radiology (ACR) reviewed mammograms performed by the ... Read More
The injectable schizophrenia drug Zyprexa Relprevv may be associated with two patient deaths; however, the Food and Drug Administration (FDA) says it does not find the evidence compelling enough to make any changes to the current prescribing or use of the injection at this time. The recommendation comes after an FDA review of a study undertaken to determine the cause of elevated levels of the medication in two patients who died after receiving injections of the medication. The agency said it was unable to exclude the possibility that the deaths were caused by rapid, but delayed, entry of the drug into ... Read More
Olympus, makers of the specialized endoscopes called duodenoscopes targeted by lawsuits tied to the superbug outbreak at UCLA Ronald Reagan Medical Center, has issued new manual reprocessing instructions for medical facilities charged with cleaning and disinfecting the duodenoscopes in an effort to curb the number of patient-to-patient infections caused by the devices. The new, validated manual reprocessing instructions are specifically for the TJF-Q180V duodenoscope and are designed to replace those provided in the original labeling. The Food and Drug Administration (FDA) has reviewed the new reprocessing instructions and validated data as part of its ongoing review of the device. Any facilities using ... Read More
Statin drugs, such as the widely prescribed Lipitor, has been shown to effectively lower cholesterol levels and protect against cardiovascular events, but the drugs may also drive down the amount of testosterone in men’s blood, leaving them with symptoms such as low libido. Statins are among the most commonly prescribed drugs in the world, but statin side effects have been called into question. As mentioned earlier, studies show statins can reduce testosterone levels, which may lead some men to seek testosterone treatment. However, testosterone drugs can increase cardiovascular risk – the very problem statins aim to fix. Statins can also ... Read More
Children and adolescents beginning treatment with second-generation antipsychotics rarely undergo metabolic screening despite the American Diabetes Association (ADA) recommending it as early as 2004, according to a new study. Second-generation antipsychotics, such as the widely prescribed Risperdal, can increase blood sugar levels and put users at risk for type 2 diabetes. This is a particular concern with children and adolescents because diabetes is a chronic condition that requires lifelong management. The ADA issued the guidelines along with the American Psychiatric Association, the American Association of Clinical Endocrinologists, and the North American Association for the Study of Obesity. They recommended that ... Read More
The mechanism that allows the drug Viagra to improve erectile dysfunction may also provide other benefits as well as risks, a new study has found. Viagra, which contains the active ingredient sildenafil, was found in animal studies to relieve nerve damage caused by diabetes. The condition, known as diabetic peripheral neuropathy, is a common but life threatening health complication in diabetic patients, and in some cases leads to amputation. A new study published online in the Public Library of Science journal PLOS ONE supports earlier studies that show Viagra may ease nerve pain by improving blood supply to the sciatic nerve. ... Read More